Logo image of NREF

NEXPOINT REAL ESTATE FINANCE (NREF) Stock Fundamental Analysis

NYSE:NREF - New York Stock Exchange, Inc. - US65342V1017 - REIT - Currency: USD

13.86  +0.01 (+0.07%)

Fundamental Rating

6

Overall NREF gets a fundamental rating of 6 out of 10. We evaluated NREF against 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. NREF scores excellent on profitability, but there are concerns on its financial health. NREF is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NREF had positive earnings in the past year.
NREF had a positive operating cash flow in the past year.
Each year in the past 5 years NREF has been profitable.
In the past 5 years NREF always reported a positive cash flow from operatings.
NREF Yearly Net Income VS EBIT VS OCF VS FCFNREF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

NREF has a Return On Assets of 0.90%. This is in the better half of the industry: NREF outperforms 72.31% of its industry peers.
NREF's Return On Equity of 9.10% is amongst the best of the industry. NREF outperforms 93.85% of its industry peers.
NREF has a Return On Invested Capital of 1.13%. This is in the better half of the industry: NREF outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NREF is in line with the industry average of 1.42%.
The 3 year average ROIC (0.29%) for NREF is below the current ROIC(1.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.9%
ROE 9.1%
ROIC 1.13%
ROA(3y)0.17%
ROA(5y)0.23%
ROE(3y)2.48%
ROE(5y)6.54%
ROIC(3y)0.29%
ROIC(5y)0.42%
NREF Yearly ROA, ROE, ROICNREF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of NREF (31.43%) is better than 92.31% of its industry peers.
In the last couple of years the Profit Margin of NREF has declined.
Looking at the Operating Margin, with a value of 49.93%, NREF belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
NREF's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 71.04%, NREF belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
NREF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 49.93%
PM (TTM) 31.43%
GM 71.04%
OM growth 3Y-21.92%
OM growth 5Y-10.46%
PM growth 3Y-21.3%
PM growth 5YN/A
GM growth 3Y-5.8%
GM growth 5Y2.25%
NREF Yearly Profit, Operating, Gross MarginsNREF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NREF is destroying value.
NREF has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NREF has been increased compared to 5 years ago.
The debt/assets ratio for NREF has been reduced compared to a year ago.
NREF Yearly Shares OutstandingNREF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
NREF Yearly Total Debt VS Total AssetsNREF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NREF has a debt to FCF ratio of 172.90. This is a negative value and a sign of low solvency as NREF would need 172.90 years to pay back of all of its debts.
With a Debt to FCF ratio value of 172.90, NREF perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
A Debt/Equity ratio of 8.93 is on the high side and indicates that NREF has dependencies on debt financing.
The Debt to Equity ratio of NREF (8.93) is worse than 87.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.93
Debt/FCF 172.9
Altman-Z N/A
ROIC/WACC0.91
WACC1.24%
NREF Yearly LT Debt VS Equity VS FCFNREF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

NREF has a Current Ratio of 0.07. This is a bad value and indicates that NREF is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.07, NREF is doing worse than 73.85% of the companies in the same industry.
NREF has a Quick Ratio of 0.07. This is a bad value and indicates that NREF is not financially healthy enough and could expect problems in meeting its short term obligations.
NREF has a worse Quick ratio (0.07) than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
NREF Yearly Current Assets VS Current LiabilitesNREF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

8

3. Growth

3.1 Past

NREF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 206.90%, which is quite impressive.
NREF shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.76% yearly.
The Revenue has grown by 97.64% in the past year. This is a very strong growth!
NREF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.01% yearly.
EPS 1Y (TTM)206.9%
EPS 3Y-8.76%
EPS 5YN/A
EPS Q2Q%189.13%
Revenue 1Y (TTM)97.64%
Revenue growth 3Y-2.84%
Revenue growth 5Y17.01%
Sales Q2Q%139.47%

3.2 Future

Based on estimates for the next years, NREF will show a small growth in Earnings Per Share. The EPS will grow by 6.86% on average per year.
NREF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.09% yearly.
EPS Next Y15.03%
EPS Next 2Y6.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.46%
Revenue Next 2Y21.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NREF Yearly Revenue VS EstimatesNREF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
NREF Yearly EPS VS EstimatesNREF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.19 indicates a rather cheap valuation of NREF.
Based on the Price/Earnings ratio, NREF is valued cheaply inside the industry as 95.38% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of NREF to the average of the S&P500 Index (27.21), we can say NREF is valued rather cheaply.
NREF is valuated cheaply with a Price/Forward Earnings ratio of 6.74.
Based on the Price/Forward Earnings ratio, NREF is valued cheaply inside the industry as 86.15% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, NREF is valued rather cheaply.
Industry RankSector Rank
PE 5.19
Fwd PE 6.74
NREF Price Earnings VS Forward Price EarningsNREF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NREF is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
NREF's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NREF is cheaper than 72.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.92
EV/EBITDA 58.01
NREF Per share dataNREF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of NREF may justify a higher PE ratio.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y6.86%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.59%, NREF is a good candidate for dividend investing.
NREF's Dividend Yield is a higher than the industry average which is at 11.56.
NREF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 14.59%

5.2 History

NREF has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NREF Yearly Dividends per shareNREF Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

NREF pays out 103.52% of its income as dividend. This is not a sustainable payout ratio.
DP103.52%
EPS Next 2Y6.86%
EPS Next 3YN/A
NREF Yearly Income VS Free CF VS DividendNREF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
NREF Dividend Payout.NREF Dividend Payout, showing the Payout Ratio.NREF Dividend Payout.PayoutRetained Earnings

NEXPOINT REAL ESTATE FINANCE

NYSE:NREF (7/2/2025, 10:29:56 AM)

13.86

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners68.52%
Inst Owner Change0.52%
Ins Owners7.1%
Ins Owner Change22.57%
Market Cap245.46M
Analysts47.5
Price Target15.56 (12.27%)
Short Float %1.01%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 14.59%
Yearly Dividend2.67
Dividend Growth(5Y)N/A
DP103.52%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-13 2025-06-13 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.27%
Min EPS beat(2)-17.97%
Max EPS beat(2)7.42%
EPS beat(4)3
Avg EPS beat(4)22.97%
Min EPS beat(4)-17.97%
Max EPS beat(4)53.19%
EPS beat(8)3
Avg EPS beat(8)8.71%
EPS beat(12)7
Avg EPS beat(12)8.31%
EPS beat(16)9
Avg EPS beat(16)6.88%
Revenue beat(2)2
Avg Revenue beat(2)21.96%
Min Revenue beat(2)1.15%
Max Revenue beat(2)42.76%
Revenue beat(4)3
Avg Revenue beat(4)16.23%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)42.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)5
Avg Revenue beat(12)15.81%
Revenue beat(16)9
Avg Revenue beat(16)75.3%
PT rev (1m)-1.61%
PT rev (3m)-6.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE 5.19
Fwd PE 6.74
P/S 1.59
P/FCF 8.92
P/OCF 8.89
P/B 0.46
P/tB 0.46
EV/EBITDA 58.01
EPS(TTM)2.67
EY19.26%
EPS(NY)2.06
Fwd EY14.83%
FCF(TTM)1.55
FCFY11.21%
OCF(TTM)1.56
OCFY11.25%
SpS8.71
BVpS30.08
TBVpS30.08
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.9%
ROE 9.1%
ROCE 1.51%
ROIC 1.13%
ROICexc 1.14%
ROICexgc 1.14%
OM 49.93%
PM (TTM) 31.43%
GM 71.04%
FCFM 17.83%
ROA(3y)0.17%
ROA(5y)0.23%
ROE(3y)2.48%
ROE(5y)6.54%
ROIC(3y)0.29%
ROIC(5y)0.42%
ROICexc(3y)0.29%
ROICexc(5y)0.42%
ROICexgc(3y)0.29%
ROICexgc(5y)0.42%
ROCE(3y)0.39%
ROCE(5y)0.55%
ROICexcg growth 3Y-11.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-11.78%
ROICexc growth 5YN/A
OM growth 3Y-21.92%
OM growth 5Y-10.46%
PM growth 3Y-21.3%
PM growth 5YN/A
GM growth 3Y-5.8%
GM growth 5Y2.25%
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 8.93
Debt/FCF 172.9
Debt/EBITDA 58.41
Cap/Depr 2.33%
Cap/Sales 0.07%
Interest Coverage 1.78
Cash Conversion 33.91%
Profit Quality 56.72%
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z N/A
F-Score7
WACC1.24%
ROIC/WACC0.91
Cap/Depr(3y)2124.95%
Cap/Depr(5y)N/A
Cap/Sales(3y)76.13%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)206.9%
EPS 3Y-8.76%
EPS 5YN/A
EPS Q2Q%189.13%
EPS Next Y15.03%
EPS Next 2Y6.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)97.64%
Revenue growth 3Y-2.84%
Revenue growth 5Y17.01%
Sales Q2Q%139.47%
Revenue Next Year41.46%
Revenue Next 2Y21.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1559.61%
EBIT growth 3Y-24.13%
EBIT growth 5Y4.77%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.08%
FCF growth 3Y14.5%
FCF growth 5YN/A
OCF growth 1Y-35.84%
OCF growth 3Y-15.94%
OCF growth 5YN/A